SCPX (Scorpius Holdings, Inc.) Short-Term Debt to Capital

Corporate company logo of Scorpius Holdings, Inc. (SCPX)

The confirmed price history on the chart shows that the debt-to-equity ratio for Scorpius Holdings, Inc. (SCPX) is 0.08. The business relies on the operation of advanced bioreactors and the modernization of sterile filling systems. New production capacities and an expanding order book for biopharmaceutical development are driving the company's growth. Overall, Scorpius Holdings, Inc. (SCPX) is developing its contract manufacturing infrastructure, becoming a key operational link for developers of modern therapies.

Ratio of Short-Term Indebtedness to Capital: NightHawk Biosciences (SCPX) for 02/21/2024 - 04/26/2025

Analytical breakdowns for Scorpius Holdings, Inc.

- stock quotes and analyst forecast:
Stock Price NightHawk Biosciences|SCPX - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Scorpius Holdings Inc.|SCPX - Enterprise Value
- book capitalization information:
Net Assets per Single Share Scorpius Holdings|SCPX - Accounting Value of Company|Market Value to Book Value Ratio nighthawkbio.com|SCPX - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Scorpius Holdings, Inc.|SCPX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Scorpius Holdings|SCPX - Aggregate Debt Obligations|Debt to Book Value Scorpius Holdings Inc.|SCPX - Amount of Long-Term Liabilities|Company Short-Term Debts Scorpius Holdings|Quick Liquidity nighthawkbio.com
- company profitability and valuation multiples indicators:
SCPX - Net Financial Result
Fundamental valuation:NightHawk Biosciences SCPX
Brand item of Scorpius Holdings Inc.

This indicator is calculated as the ratio of liabilities with a maturity of up to one year to equity, measuring the balance sheet's dependence on short-term borrowing and the risk of cash flow gaps as borrowing costs rise. For Scorpius Holdings, Inc. (SCPX), stable cash flow from the Inertia CDMO segment should offset the pressure of short-term debt, which is reflected in the current ratio of short-term borrowed capital to equity.

Key competitors

Short-Term Debt to Capital IQV|LH (LabCorp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital MEDP (Medpace Holdings, Inc.)|Short-Term Debt to Capital ICON Corp ICLR|CRL - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital EVO (Evotec AG)|Fortrea Corp (FTRE) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Lifecore Biomedical, Inc.|OABI (OmniAb, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital inotivco.com|Short-Term Debt to Equity Ratio CDMO (Avid Bioservices)|CTLT (Catalent Inc.) - Ratio of Short-Term Indebtedness to Capital